only with


Divi’s Laboratories Ltd.
Divi’s Laboratories
Divi’s Laboratories Ltd. live price is ₹ 0.00. Price change 0.00, 0.00 percent.
₹ 0.00
0.00 (0.00)%
Healthcare
Large-cap - With a market cap of ₹2399.82 Cr.
| EX-Date | Purpose |
|---|---|
| 29 05 2021 | Final Dividend & Audited Results |
| 07 08 2021 | Quarterly Results |
| 06 11 2021 | Quarterly Results |
| 04 02 2022 | Quarterly Results |
| 11 02 2022 | Quarterly Results (Revised) |
| 23 05 2022 | Dividend & Audited Results |
| 12 08 2022 | Quarterly Results |
| 07 11 2022 | Quarterly Results |
| 03 02 2023 | Quarterly Results |
| 20 05 2023 | Final Dividend & Audited Results |
| 14 08 2023 | Quarterly Results |
| 06 11 2023 | Quarterly Results |
| 10 02 2024 | Quarterly Results |
| 09 11 2024 | Quarterly Results |
| 03 02 2025 | Quarterly Results |
| 17 05 2025 | Dividend & Audited Results |
| 07 11 2025 | Quarterly Results |
| 11 02 2026 | Quarterly Results |
| 23 05 2026 | Final Dividend & Audited Results |
| 01 08 2026 | Quarterly Results |
News
Divis Laboratories informs about outcome of board meeting
Divi’s Laboratories reports Profit after tax of Rs 8910.00 Mln, in the June 2026 quarter
Divi’s Laboratories informs about cessation of SMP
Divi’s Laboratories informs about earnings call
Divi’s Laboratories informs about board meeting
Divis Laboratories informs about AGM
Divis Laboratories informs about deduction of Income tax at source from payment of dividend
Divi’s Laboratories’ consolidated net profit rises 13% in Q4
The total consolidated income of the company has increased by 11.79% at Rs 2,986.00 crore for Q4FY26
Divi’s Lab - Quaterly Results
Divi’s Lab reports Profit after tax of Rs 7560.00 Mln, in the March 2026 quarter
Divi’s Laboratories informs about closing of trading window
Divi’s Lab - Quaterly Results
Divi’s Lab reports Profit after tax of Rs 5980.00 Mln, in the December 2025 quarter
Divis Laboratories informs about board meeting
Divi’s Laboratories informs about certificate
Divi’s Laboratories informs about closure of trading window
Divi’s Laboratories reports 35% rise in Q2 consolidated net profit
The consolidated total income of the company increased by 17.02% at Rs 2,860.00 crore for Q2FY26
Divi’s Lab - Quaterly Results
Divi’s Lab reports Profit after tax of Rs 6960.00 Mln, in the September 2025 quarter
Divi’s Laboratories informs about transcript of earnings call
Divis Laboratories informs about press release
Divi’s Laboratories reports 27% rise in Q1 consolidated net profit
The total consolidated income of the company increased by 15.11% at Rs 2529.00 crore for Q1FY26
Divi’s Lab - Quaterly Results
Divi’s Lab - Quaterly Results
Divi’s Lab reports Profit after tax of Rs 5570.00 Mln, in the June 2025 quarter
Divi’s Lab - Quaterly Results
Divis Laboratories informs about board meeting
Divi’s Laboratories informs about certificate
Divi’s Laboratories informs about closure of trading window
Divi’s Laboratories zooms on inking pact with global pharma company
Under this agreement, the company will be manufacturing and supplying advanced intermediates as per the commercial terms agreed between the parties
Divi’s Laboratories inks pact with global pharma company
Under this agreement, the company will be manufacturing and supplying advanced intermediates as per the commercial terms agreed between the parties
Divi’s Laboratories informs about updates
Divis Laboratories board approves dividend
Divi’s Lab - Quaterly Results
Divi’s Lab - Quaterly Results
Divi’s Lab - Quaterly Results
Divi’s Lab reports Profit after tax of Rs 6670.00 Mln, in the March 2025 quarter
Divis Laboratories informs about annual secretarial compliance report
Divi’s Laboratories informs about cessation of SMP
Divi’s Laboratories surges on inking supply agreement with global pharmaceuticals firm
The company expects meaningful revenue contribution from this long-term agreement
Divi’s Laboratories inks supply agreement with global pharmaceuticals firm
The company expects meaningful revenue contribution from this long-term agreement
Divis Laboratories informs about trading window closure
Divi’s Laboratories informs about cessation of senior management personnel
Divi’s Laboratories informs about disclosure
Divi’s Laboratories informs about integrated filing
Divi’s Lab - Quaterly Results
Divi’s Lab reports Profit after tax of Rs 5940.00 Mln, in the December 2024 quarter
Divi’s Lab - Quaterly Results
Divi’s Lab - Quaterly Results
Divi’s Laboratories starts commercial operations of Unit III greenfield project at Andhra Pradesh
The company has commenced commercial operations from a part of the Phase I of Unit III greenfield project from January 01, 2025
Divi’s Laboratories informs about disclosure
Divi’s Laboratories informs about disclosure
Divi’s Laboratories’ Q2FY25 consolidated net profit rises 47% to Rs 510 crore
Consolidated total income of the company increased by 22.51% at Rs 2,444 crore for Q2FY25
Divi’s Lab - Quaterly Results
Divi’s Lab reports Profit after tax of Rs 5180.00 Mln, in the September 2024 quarter
Divi’s Lab - Quaterly Results
Divi’s Lab - Quaterly Results
Divi’s Laboratories informs about certificate
Divi’s Laboratories informs about closure of trading window
Divi’s Laboratories informs about notice of postal ballot
Divi’s Laboratories surges on reporting 17% rise in Q3 consolidated net profit
Consolidated total income of the company increased by 7.08% at Rs 1950 crore for Q3FY24
Divi’s Laboratories reports 17% rise in Q3 consolidated net profit
Consolidated total income of the company increased by 7.08% at Rs 1950 crore for Q3FY24
Divi’s Lab - Quaterly Results
Divi’s Lab - Quaterly Results
Divi’s Lab reports Profit after tax of Rs 3580.00 Mln, in the December 2023 quarter
Divi’s Lab - Quaterly Results
Divi’s Laboratories informs about certificate
Divi’s Laboratories informs about closure of trading window
Divi’s Laboratories informs about disclosure
Divi’s Laboratories shines despite reporting 29% fall in Q2 consolidated net profit
Total consolidated income of the company increased by 3.10% at Rs 1995 crore for Q2FY24
Divi’s Laboratories informs about outcome of board meeting
Divi’s Laboratories informs about outcome of board meeting
Divi’s Laboratories reports 29% fall in Q2 consolidated net profit
Total consolidated income of the company increased by 3.10% at Rs 1995 crore for Q2FY24
Divi’s Lab - Quaterly Results
Divi’s Lab reports Profit after tax of Rs 3420.00 Mln, in the September 2023 quarter
Divi’s Lab - Quaterly Results
Divi’s Lab - Quaterly Results
Divi’s Laboratories informs about closure of trading window
Divi’s Laboratories informs about earnings call transcript
Divi’s Laboratories informs about newspapers publication
Divi’s Laboratories reports 49% fall in Q1 consolidated net profit
Total consolidated income of the company decreased by 20.66% at Rs 1859 crore for Q1FY24
Divi’s Lab - Quaterly Results
Divi’s Lab - Quaterly Results
Divi’s Lab reports Profit after tax of Rs 3450.00 Mln, in the June 2023 quarter
Divi’s Lab - Quaterly Results
Divi’s Laboratories informs about secretarial compliance report
Divi’s Laboratories reports 64% fall in Q4 consolidated net profit
Total consolidated income of the company decreased by 21.55% at Rs 2,016.92 crore for Q4FY23
Divi’s Lab - Quaterly Results
Divi’s Lab - Quaterly Results
Divi’s Lab - Quaterly Results
Divi’s Lab reports Profit after tax of Rs 3187.90 Mln, in the March 2023 quarter
Divi’s Laboratories informs about certificate
Divi’s Laboratories reports 66% fall in Q3 consolidated net profit
Total consolidated income of the company decreased by 27.41% to Rs 1821.93 crore for Q3FY23
Divi’s Lab - Quaterly Results
Divi’s Lab - Quaterly Results
Divi’s Lab - Quaterly Results
Divi’s Laboratories informs about conference call
Divi’s Laboratories reports 19% fall in Q2 consolidated net profit
Total consolidated income of the company marginally fall by 3.59% at Rs 1934.62 crore for Q2FY23
Divi’s Lab reports Profit after tax of Rs 4868.50 Mln, in the September 2022 quarter
Divi’s Lab - Quaterly Results
Divi’s Lab - Quaterly Results
Divi’s Lab - Quaterly Results
Divi’s Laboratories informs about board meeting
Divi’s Laboratories reports 26% rise in Q1 consolidated net profit
Total consolidated income of the company increased by 17.34% at Rs 2342.91 crore for Q1FY23

